ASO Author Reflections: Peri-operative Chemotherapy for Resectable Colorectal Liver Metastases

被引：0
|
作者：
Di Martino, Marcello [1 ]
Primavesi, Florian [2 ,3 ]
机构：
[1] Univ Autonoma Madrid UAM, Hosp Univ La Princesa, Inst Invest Sanitaria Princesa IIS IP, Dept Gen & Digest Surg,HPB Unit, Madrid, Spain
[2] Liverpool Univ Hosp NHS Fdn Trust, Aintree Univ Hosp, Liverpool, Merseyside, England
[3] Salzkammergutklinikum Vocklabruck, Vocklabruck, Austria
来源：
ANNALS OF SURGICAL ONCOLOGY | 2022年 / 29卷 / 11期
关键词：
SURGERY; FOLFOX4;
D O I：
10.1245/s10434-022-12176-x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6843 / 6844
页数：2
相关论文
共 50 条
  • [31] Efficacy of neoadjuvant chemotherapy for initially resectable colorectal liver metastases: A retrospective cohort study
    Takeda, Kazuhisa
    Sawada, Yu
    Yabushita, Yasuhiro
    Honma, Yuki
    Kumamoto, Takafumi
    Watanabe, Jun
    Matsuyama, Ryusei
    Kunisaki, Chikara
    Misumi, Toshihiro
    Endo, Itaru
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 14 (07) : 1281 - 1294
  • [32] Preoperative chemotherapy in upfront resectable colorectal liver metastases: New elements for an old dilemma?
    Bernardi, Lorenzo
    Roesel, Raffaello
    Aghayan, Davit L.
    Majno-Hurst, Pietro E.
    De Dosso, Sara
    Cristaudi, Alessandra
    CANCER TREATMENT REVIEWS, 2024, 124
  • [33] Perioperative second-line chemotherapy is beneficial for resectable liver metastases that occur during or early after adjuvant chemotherapy for colorectal cancer
    Xu, Da
    Zhu, Hai-Bin
    Wang, Yan-Yan
    Jin, Ke-Min
    Yan, Xiao-Luan
    Li, Juan
    Wang, Kun
    Xing, Bao-Cai
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022, 37 (04) : 805 - 814
  • [34] The Role of Preoperative Chemotherapy in the Management of Synchronous Resectable Colorectal Liver Metastases: A Meta-Analysis
    Tepelenis, Kostas
    Pappas-Gogos, Georgios
    Ntellas, Panagiotis
    Tsimogiannis, Konstantinos
    Dadouli, Katerina
    Mauri, Davide
    Glantzounis, Georgios K. K.
    CURRENT ONCOLOGY, 2023, 30 (05) : 4499 - 4511
  • [35] The role of neoadjuvant chemotherapy for resectable colorectal liver metastases: a systematic review and meta-analysis
    Liu, Wei
    Zhou, Jian-Guo
    Sun, Yi
    Zhang, Lei
    Xing, Bao-Cai
    ONCOTARGET, 2016, 7 (24) : 37277 - 37287
  • [36] Surgical timing after preoperative chemotherapy is associated with oncologic outcomes in resectable colorectal liver metastases
    Sutton, Thomas L.
    Wong, Liam H.
    Walker, Brett S.
    Dewey, Elizabeth N.
    Eil, Robert L.
    Ibewuike, Uchechukwu
    Chen, Emerson Y.
    Rocha, Flavio G.
    Billingsley, Kevin G.
    Mayo, Skye C.
    JOURNAL OF SURGICAL ONCOLOGY, 2022, 125 (08) : 1260 - 1268
  • [37] Systematic review of systemic adjuvant, neoadjuvant and perioperative chemotherapy for resectable colorectal-liver metastases
    Khoo, Emily
    O'Neill, Stephen
    Brown, Ewan
    Wigmore, Stephen J.
    Harrison, Ewen M.
    HPB, 2016, 18 (06) : 485 - 493
  • [38] The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score
    Yonekawa, Yoshihiko
    Uehara, Kay
    Mizuno, Takashi
    Aiba, Toshisada
    Ogura, Atsushi
    Mukai, Toshiki
    Yokoyama, Yukihiro
    Ebata, Tomoki
    Kodera, Yasuhiro
    Nagino, Masato
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (01) : 126 - 134
  • [39] Hepatectomy versus Chemotherapy for Resectable Colorectal Liver Metastases in Progression after Perioperative Chemotherapy: Expanding the Boundaries of the Curative Intent
    Famularo, Simone
    Milana, Flavio
    Cimino, Matteo
    Procopio, Fabio
    Costa, Guido
    Galvanin, Jacopo
    Paoluzzi Tomada, Elisa
    Bunino, Francesca Margherita
    Palmisano, Angela
    Donadon, Matteo
    Torzilli, Guido
    CANCERS, 2023, 15 (03)
  • [40] Peri-Operative Chemotherapy for Bladder Cancer: A Survey of Providers to Determine Barriers and Enablers
    Walker, Melanie
    Doiron, R. Christopher
    French, Simon D.
    Brennan, Kelly
    Feldman-Stewart, Deb
    Siemens, D. Robert
    Mackillop, William J.
    Booth, Christopher M.
    BLADDER CANCER, 2018, 4 (01) : 49 - 65
12345